Regulatory Flexibilities and Guidances for Addressing the Challenges of COVID-19 in the EU: What Can We Learn from Company Experiences?

The COVID-19 pandemic required urgency in the development and delivery of effective vaccines and therapeutics; meanwhile, ongoing clinical research, regulation and supply for other much-needed therapeutics and vaccines needed to be sustained. In Europe, the European Commission, the European Medicine...

Descripción completa

Detalles Bibliográficos
Autores principales: Klein, Kevin, Stolk, Pieter, Tellner, Pär, Acha, Virginia, Montagne, Sarah, Stöckert, Isabelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821789/
https://www.ncbi.nlm.nih.gov/pubmed/35129827
http://dx.doi.org/10.1007/s43441-022-00383-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821789/
https://www.ncbi.nlm.nih.gov/pubmed/35129827
http://dx.doi.org/10.1007/s43441-022-00383-3

Ejemplares similares